Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate

 

Latest News

Date posted: 2/18/2013

In 2009, millions of diabetes patients around the world switched to Actos thinking it was a safer alternative after rival drug Avandia was linked to heart problems. Now, those same patients are reeling in the wake of several reports linking Actos to bladder cancer.

While patients search for yet another diabetes treatment, thousands who have been diagnosed with bladder cancer after taking Actos are moving forward with legal claims against the manufacturer, Takeda Pharmaceuticals, for their failure to warn of the dangers.

Fortunately, bladder cancer is considered highly treatable, with a high survival rate if discovered early. However, the treatment can be considerable and ongoing.

In 2011, both the FDA and European Medicines Agency warned that extended use of Actos could be associated with an increased risk of bladder cancer, after a French study of nearly 180,000 patients showed a 40% increased risk related to the drug.

France and Germany moved quickly to ban Actos over safety concerns. In the U.S., the drug remains available and is still prescribed heavily. However, those affected have greater legal rights than victims in other countries.

So far, more than 1,200 patients have filed an Actos lawsuit over bladder cancer. Experts predict as many as 10,000 may eventually come forward to get help.* Due to the volume, the cases have been consolidated to a special multi-district federal court in Louisiana.

Judge Rebecca Doherty has scheduled the first Actos lawsuit trial to start in 2014, therefore, time may be limited for victims to file a claim.

If you or a loved one were diagnosed with bladder cancer after taking Actos, it is important to speak with a lawyer about your legal rights as soon as possible.

Cases such as these against large drug companies can be very complex. Therefore, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.

For more information on the research, side effects and litigation news related to Actos, or to speak with a lawyer, contact us today. We are available 24 hours a day to help.

 

*bloomberg.com/news/2011-12-01/takeda-may-face-10-000-u-s-suits-over-actos-cancer-claims.html